Ono to Fight Prof. Honjo’s Lawsuit over Opdivo Royalties

July 7, 2020
Ono Pharmaceutical will fight the lawsuit filed by the Nobel laureate Tasuku Honjo over the patent royalties for the anti-PD-1 antibody Opdivo (nivolumab), the company said on July 6 in a statement after receiving the compliant. Kyoto University professor Honjo...read more